Resistant Cancer Cell Line Collection

Jindrich Cinatl
Dr Petra Joh-Forschungshaus
Frankfurter Stiftung für krebskranke Kinder
Frankfurt am Main, Germany

Wass-Michaelis Research Group
School of Biosciences
University of Kent
Kent, UK
Search     About     Help     Contact     Disclaimer
Investigate Data for a single Drug: bortezomib
Bortezomib - Drug Information
Basic information about the drug is displayed below. This has been extracted from the Wikipedia entry for the drug - https://en.wikipedia.org/wiki/Bortezomib
Bortezomib.svg
Bortezomib-from-PDB-2F16-3D-balls.png
Clinical data
Trade names Velcade
AHFS/Drugs.com Monograph
MedlinePlus a607007
Pregnancy
category		 US: D (Evidence of risk)
Routes of
administration		 Intravenous
ATC code L01XX32 (WHO)
Pharmacokinetic data
Protein binding 83%
Biological half-life 9-15 hours
Identifiers
Synonyms cisplatinum, platamin, neoplatin, cismaplat, cis-diamminedichloridoplatinum(II) (CDDP)
CAS Number 179324-69-7
PubChem CID 387447
DrugBank DB00188
ChemSpider 343402
ChEMBL CHEMBL325041
PDB ligand BO2 (PDBe, RCSB PDB)
Bortezomib Drug sensitivity Data
The table and barchart show all drug sensitivity data for bortezomib

In the bar chart resistant sub-lines are shown in a lighter shade of the parental cell line